doi: 10.3389/fphar.2023.1147414 Received 18 January 2023 Accepted 22 February 2023 Published 02 March 2023 Volume 14 - 2023 Edited by Zhihao Liu, Dalian Medical University, China Reviewed by Ral Gonzalez Ojeda, University of Galway, Ireland Hang Liu, University of California, Los Angeles, United States Updates Copyright 2023 Pei, Pan, Wei and Hua
Anyone with significant hair loss should seek a proper diagnosis rather than relying on an unproven cosmetic
Romero-Haro AA, Figuerola J, Alonso-Alvarez C
Tagrisso is also approved to treat NSCLC with EGFR mutations in the first line metastatic setting as a monotherapy and in combination with chemotherapy, and as an adjuvant treatment for early-stage disease
In addition, Greenwell Lifesciences has a vast experience and uses the latest and innovative packaging methods to deliver the products in a given time with safety